Opportunity Information: Apply for RFA DA 19 038
The Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1; Clinical Trial Not Allowed) is a National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) cooperative agreement funding opportunity (RFA-DA-19-038) designed to create a central hub for organizing, harmonizing, analyzing, and broadly sharing research data generated by companion SCORCH awards. In particular, it is paired with RFA-DA-19-037, which focuses on generating single-cell datasets from one or more brain regions relevant to opioid use disorder (OUD) and persistent HIV infection. This UM1 opportunity does not fund clinical trials; instead, it supports the infrastructure and scientific leadership needed to make the resulting datasets maximally useful to the research community.
At the core of the opportunity is the creation of a data coordination, analysis, and outreach center that will make NIDA-funded single-cell data and other molecular data related to HIV and substance use disorders (SUD) FAIR: Findable, Accessible, Interoperable, and Reusable. The practical goal is to ensure that datasets produced across different projects, platforms, and sites can be discovered easily, accessed appropriately, combined or compared reliably, and reused for new questions over time. Because single-cell methods can produce complex, high-dimensional outputs with many potential sources of technical variation, this center is meant to drive harmonization efforts so that data coming from different SCORCH projects can be integrated into coherent, standardized resources rather than remaining siloed.
A major emphasis is on enabling immediate and future data mining by the broader scientific community. In the near term, harmonized single-cell HIV/SUD datasets are expected to accelerate discovery of biomarkers and biological pathways linked to HIV persistence, opioid exposure, and OUD-relevant neurobiology. This includes identifying cell-type-specific responses to opioids, understanding how HIV-related processes may differ across neural and immune cell populations, and pinpointing candidate molecular targets that could inform therapeutic intervention strategies. Over the longer term, the program is explicitly designed to keep the datasets valuable as analytical methods improve. By investing in robust data organization, standards, and dissemination now, NIDA aims to maximize the return on the original investment in data generation, allowing future researchers to reanalyze the same resources using newer computational approaches, improved reference atlases, and emerging integrative methods.
The award mechanism is a cooperative agreement, which typically means NIDA expects substantial programmatic involvement and coordination between awardees and the agency. In practice, that implies the center will not just passively store data; it will actively coordinate with data-generating projects, help define common data elements and metadata expectations, support cross-project quality control and normalization strategies, and facilitate data release processes that align with FAIR principles and community standards. The "scientific outreach" component signals that the center is also responsible for helping the community actually use the data, which often includes documentation, user support, communication of updates, and efforts that lower barriers for outside investigators to discover and analyze the datasets.
This is a discretionary funding opportunity in the Education and Health activity category, tied to CFDA number 93.279, and it was released by NIH with an original closing date of May 8, 2019 (created April 1, 2019). Eligible applicants are broad and include many types of U.S. governmental entities (state, county, city/township, special district), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, tribal organizations (including those other than federally recognized governments), public housing authorities/Indian housing authorities, nonprofits (both 501(c)(3) and non-501(c)(3), excluding institutions of higher education when specified), for-profit organizations (other than small businesses), and small businesses. The opportunity also highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations).
Overall, RFA-DA-19-038 is best understood as the program’s integrative backbone: it supports the coordinated data ecosystem that turns multiple single-cell projects into a unified, reusable public resource for HIV and SUD research. The intended outcome is not only better organization and stewardship of complex single-cell datasets, but also faster scientific discovery now and sustained usefulness of these data as computational biology and data science continue to advance.Apply for RFA DA 19 038
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2019-04-01.
- Applicants must submit their applications by 2019-05-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the SCORCH Program: Data Coordination, Analysis, and Scientific Outreach (UM1) opportunity?
The Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach is an NIH National Institute on Drug Abuse (NIDA) cooperative agreement funding opportunity (RFA-DA-19-038). Its purpose is to establish a central hub that organizes, harmonizes, analyzes, and broadly shares research data generated by companion SCORCH awards.
Which NIH institute is sponsoring this funding opportunity?
This opportunity is sponsored by the National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA).
What is the funding mechanism for this opportunity?
The award mechanism is a cooperative agreement (UM1). This generally indicates substantial programmatic involvement by NIDA and active coordination between the awardee(s) and the agency.
Are clinical trials allowed under this UM1 opportunity?
No. The opportunity is explicitly labeled "Clinical Trial Not Allowed." It supports infrastructure and scientific leadership for data coordination, analysis, and outreach rather than funding clinical trials.
What does this UM1 award actually fund if it does not fund clinical trials?
It supports the creation and operation of a data coordination, analysis, and scientific outreach center. The center is intended to serve as a program backbone for organizing, harmonizing, analyzing, and sharing SCORCH-related single-cell and other molecular datasets tied to HIV and substance use disorders (SUD), including opioid use disorder (OUD).
How does RFA-DA-19-038 relate to RFA-DA-19-037?
RFA-DA-19-038 is paired with RFA-DA-19-037. While RFA-DA-19-037 focuses on generating single-cell datasets from one or more brain regions relevant to opioid use disorder and persistent HIV infection, RFA-DA-19-038 focuses on coordinating, harmonizing, analyzing, and sharing the resulting datasets so they become a coherent, reusable resource.
What is the central goal of the data coordination, analysis, and outreach center?
The center is intended to make NIDA-funded single-cell data and other molecular data related to HIV and substance use disorders FAIR: Findable, Accessible, Interoperable, and Reusable. Practically, that means the data should be easy to discover, accessible in appropriate ways, usable across platforms and projects, and reusable over time for new research questions.
What does FAIR mean in the context of this opportunity?
FAIR refers to data being Findable, Accessible, Interoperable, and Reusable. In this program, FAIR principles are emphasized so that datasets produced across different projects, platforms, and sites can be discovered easily, accessed appropriately, combined or compared reliably, and reused for future analyses.
Why is harmonization a major focus for SCORCH datasets?
Single-cell methods generate complex, high-dimensional data that can vary due to technical differences across platforms and sites. The center is meant to drive harmonization so data from different SCORCH projects can be integrated into standardized resources instead of remaining siloed and difficult to compare.
What kinds of data are expected to be coordinated under this program?
Based on the description, the center will coordinate NIDA-funded single-cell datasets as well as other molecular data related to HIV and substance use disorders (SUD). The paired data-generation effort (RFA-DA-19-037) specifically references single-cell datasets from brain region(s) relevant to OUD and persistent HIV infection.
What does "scientific outreach" mean for this center?
Scientific outreach indicates responsibility beyond simply storing data. The center is expected to help the broader community discover and use the datasets. This can include documentation, user support, communication of updates, and other efforts that lower barriers for outside investigators to access and analyze the harmonized resources.
What role does NIDA play given this is a cooperative agreement?
Because it is a cooperative agreement, NIDA expects substantial involvement and coordination. The description indicates the center will actively coordinate with data-generating projects, help define common data elements and metadata expectations, support cross-project quality control and normalization strategies, and facilitate data release processes aligned with FAIR principles and community standards.
How is this opportunity expected to benefit the broader research community?
The program emphasizes enabling immediate and future data mining by the broader scientific community. In the near term, harmonized datasets are expected to accelerate discovery related to biomarkers and biological pathways tied to HIV persistence and opioid exposure, including cell-type-specific responses and candidate molecular targets. Over the longer term, robust standards and dissemination are intended to keep the datasets valuable as analytical methods improve.
What scientific areas does the opportunity emphasize?
The focus is on research data related to HIV and substance use disorders, including opioid exposure and opioid use disorder (OUD), and on understanding opioid responses in the context of HIV. The paired program references brain regions relevant to OUD and persistent HIV infection, and the UM1 center supports integrated analysis and dissemination of these types of datasets.
What is the practical outcome NIDA is aiming for with this program?
The intended outcome is a coordinated data ecosystem that turns multiple single-cell projects into a unified, reusable resource for HIV and SUD research. This includes better organization and stewardship of complex datasets, faster scientific discovery in the near term, and sustained usefulness of the data as computational methods evolve.
What is the CFDA number and activity category for this opportunity?
The opportunity is tied to CFDA number 93.279 and is described as a discretionary funding opportunity in the Education and Health activity category.
When was this funding opportunity created and when did it originally close?
The opportunity was created on April 1, 2019, and the original closing date was May 8, 2019.
Who is eligible to apply for RFA-DA-19-038?
Eligibility is broad and includes many U.S. governmental entities (state, county, city/township, special district), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, tribal organizations (including those other than federally recognized governments), public housing authorities/Indian housing authorities, nonprofits (501(c)(3) and non-501(c)(3), excluding institutions of higher education when specified), for-profit organizations (other than small businesses), and small businesses.
Are minority-serving institutions and community-based organizations included as eligible applicants?
Yes. The opportunity highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations, among others.
Can federal agencies, U.S. territories, or foreign organizations apply?
Yes. The eligibility description includes eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations).
Is this opportunity best described as a data generation award or a data infrastructure award?
Based on the description, RFA-DA-19-038 is primarily a data infrastructure, coordination, analysis, and outreach award. The generation of single-cell datasets is associated with the paired opportunity (RFA-DA-19-037), while this UM1 is described as the integrative backbone that makes those datasets maximally useful.
What kinds of coordination activities are implied by "central hub" and "integrative backbone"?
The description implies active coordination across companion SCORCH projects, including harmonizing datasets across different platforms and sites, defining common data elements and metadata expectations, supporting quality control and normalization strategies, and facilitating broad sharing and data release aligned with FAIR principles and community standards.
Why does the opportunity emphasize long-term reuse of data?
The program is explicitly designed to keep datasets valuable as analytical methods improve. By investing in robust data organization, standards, and dissemination now, NIDA aims to maximize the return on the original investment in data generation and enable future researchers to reanalyze the same resources using newer computational approaches and emerging integrative methods.
Browse more opportunities from the same category: Education, Health
Next opportunity: Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
Previous opportunity: FY19 Small Business Innovation Research Program Phase II
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 19 038
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 19 038) also looked into and applied for these:
| Funding Opportunity |
|---|
| Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Apply for RFA DA 19 039 Funding Number: RFA DA 19 039 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 19 047 Funding Number: RFA CA 19 047 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 19 242 Funding Number: PAR 19 242 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed) Apply for PAR 19 246 Funding Number: PAR 19 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional) Apply for PAR 19 256 Funding Number: PAR 19 256 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Apply for PAR 19 258 Funding Number: PAR 19 258 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 19 259 Funding Number: PAR 19 259 Agency: National Institutes of Health Category: Education, Health Funding Amount: $10,000,000 |
| Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed) Apply for RFA DA 20 005 Funding Number: RFA DA 20 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Apply for PAR 19 264 Funding Number: PAR 19 264 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 041 Funding Number: RFA AI 19 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Apply for PAR 19 277 Funding Number: PAR 19 277 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional) Apply for RFA DA 20 012 Funding Number: RFA DA 20 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional) Apply for RFA DA 20 011 Funding Number: RFA DA 20 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 19 278 Funding Number: PAR 19 278 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Apply for PAR 19 279 Funding Number: PAR 19 279 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 20 017 Funding Number: RFA DA 20 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Apply for PAR 19 280 Funding Number: PAR 19 280 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 20 018 Funding Number: RFA DA 20 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) Apply for PAR 19 285 Funding Number: PAR 19 285 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Apply for PAR 19 283 Funding Number: PAR 19 283 Agency: National Institutes of Health Category: Education, Health Funding Amount: $280,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 19 038", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
